In heterologous expression systems, KCNE2 has been demonstrated to interact with multiple ␣-subunits of voltage-dependent cation channels and modulate their functions. However, the physiological and pathological roles of KCNE2 in cardiomyocytes are poorly understood. The present study aimed to investigate the effects of bidirectional modulation of KCNE2 expression on action potential (AP) duration (APD) and voltage-dependent K ϩ channels in cardiomyocytes. Adenoviral gene delivery and RNA interference were used to either increase or decrease KCNE2 expression in cultured neonatal and adult rat or neonatal mouse ventricular myocytes. Knockdown of KCNE2 prolonged APD in both neonatal and adult myocytes, whereas overexpression of KCNE2 shortened APD in neonatal but not adult myocytes. Consistent with the alterations in APD, KCNE2 knockdown decreased transient outward K ϩ current (Ito) densities in neonatal and adult myocytes, whereas KCNE2 overexpression increased I to densities in neonatal but not adult myocytes. Furthermore, KCNE2 knockdown accelerated the rates of I to activation and inactivation, whereas KCNE2 overexpression slowed I to gating kinetics in neonatal but not adult myocytes. Delayed rectifier K ϩ current densities were remarkably affected by manipulation of KCNE2 expression in mouse but not rat cardiomyocytes. Simulation of the AP of a rat ventricular myocyte with a mathematical model showed that alterations in I to densities and gating properties can result in similar APD alterations in KCNE2 overexpression and knockdown cells. In conclusion, endogenous KCNE2 in cardiomyocytes is important in maintaining cardiac electrical stability mainly by regulating I to and APD. Perturbation of KCNE2 expression may predispose the heart to ventricular arrhythmia by prolonging APD.
. Despite the evidence in vitro, there are intense debates over the putative role of KCNE2 in native cardiac myocytes for two major reasons. First, reports on the expression level of KCNE2 protein in the ventricle are controversial; some studies have reported low expression compared with others (4 -6, 8, 14, 19, 21, 34) . Second, evidence about KCNE2 regulating K v channels is almost all from heterologous expression experiments. The native cardiomyocyte is a far more complicated system, where multiple ion channels and signaling pathways are present and their functions are interwoven to maintain cardiac electrical stability. What happens in a heterologous expression system may just stay in it. Nevertheless, KCNE2 is important in maintaining cardiac electrical stability because mutations or a polymorphism in the KCNE2 gene have been linked to long QT syndrome (LQT6) and familial atrial fibrillation/short QT syndrome (2, 24, 31) . Furthermore, alterations in KCNE2 expression have been linked to cardiac arrhythmia in diseased hearts (8) . To understand the role of KCNE2 in ventricular repolarization and arrhythmogenic mechanism(s) of LQT6 and diseased hearts, it is of particular importance to determine the precise roles of endogenous KCNE2 in native cardiomyocytes.
The first investigation regarding the direct physiological role of KCNE2 in the heart was performed by Abbott and colleagues in KCNE2 gene knockout mice. The authors demonstrated that targeted deletion of the KCNE2 gene impaired ventricular repolarization via disruption of rapidly activating, slowly inactivating K ϩ current (I K,slow1 ) and fast transient outward K ϩ current (I to,f ) (22) . Their elegant work confirmed that KCNE2 exists in ventricles and plays an important role in ventricular repolarization. Although the gene knockout technique is strong in providing insights into physiological roles of the target gene, it has disadvantages. It should be taken into account that both direct and indirect actions of gene products during embryo development may contribute to the observed phenotypes. Furthermore, we may not deduce the roles of the altered gene in pathological conditions from phenotypes of gene knockout.
With these considerations, we explored the effects of modulation of endogenous KCNE2 expression on the action poten-tial (AP) and major K v channels, including transient outward K ϩ (I to ), delayed rectifier K ϩ (I K ), and inward rectifier K ϩ (I K1 ) currents, in native neonatal rat ventricular myocytes (NRVMs) and adult rat ventricular myocytes (ARVMs). Here, we showed that bidirectional modulation of KCNE2 expression heterogeneously regulates AP duration (APD) in NRVMs and ARVMs. Concomitantly, I to and I K , the two major repolarization K v channels in rat cardiomyocytes, were heterogeneously regulated by bidirectional manipulation of KCNE2 expression.
METHODS
Isolation and culture of adult rat ventricular epicardial myocytes. All experimental procedures and protocols on animals were approved by the Institutional Animal Care and Use Committee of Shenzhen University and comply with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23, Revised 1996) . Adult (2-3 mo old) Sprague-Dawley rats (200 -250 g) were anesthetized with a mixture of 86 mg/100 g urethane and 3.3 mg/100 g chloralose (urethane and chloralose were dissolved in normal saline solution to make final concentrations of 13.3% and 0.5%, respectively, 0.65 ml/100 g ip). Single myocytes were isolated from the epicardial of left ventricles under sterile conditions, as previously described with minor revisions (32) . In brief, the heart was removed from the chest, cleaned and flushed with nominally Ca 2ϩ -free Tyrode solution consisting of (in mM) 137 NaCl, 5.4 KCl, 1.2 MgCl2, 1.2 NaH2PO4, 10 glucose, and 20 HEPES (pH 7.4), and perfused using a Langendorff apparatus. Perfusion began with nominally Ca 2ϩ -free Tyrode solution for 5 min at 37°C and then switched to enzyme solution with 0.5 mg/ml collagenase (type II, Worthington) and 0.06 mg/ml protease (type XIV, Sigma) for 20 -25 min. The free wall of the left ventricle was dissected into outer (epicardial) and inner (endocardial) halves. The outer halve was minced and gently triturated for 15 min to release single myocytes. The supernatant was collected, and cells were pelleted by low-speed centrifugation. Cell pellets were resuspended in HEPES-buffered solution containing (in mM) 137 NaCl, 5.4 KCl, 1.2 MgCl 2, 1.2 NaH2PO4, 1 CaCl2, 20 glucose, and 20 HEPES (pH 7.4, adjusted with NaOH). For culture, cells were seeded on 30-mm laminin-coated coverslips at a density of 10 5 cells/coverslip and cultured in Medium 199 (Sigma) supplemented with 5 mM creatine, 2 mM L-carnitine, 5 mM taurine, 0.1 insulin-transferring selenium X, 1% penicillin-streptomycin, and 20 mM HEPES (pH adjusted to 7.2 with NaHCO 3) (27) .
Isolation and culture of NRVMs or neonatal mouse ventricular myocytes. NRVMs were isolated from 2-day-old Sprague-Dawley rats and cultured as previously described (13) . In brief, ventricles were obtained after decapitation, immersed in PBS, and minced with scissors. The small pieces of ventricular tissue were digested with 0.25% Trypsin-EDTA in PBS at 37°C. Isolated cells were placed into FBS and pelleted by centrifugation at 1,000 rpm for 5 min. The pelleted cells were resuspended in DMEM containing 10% FBS and 1% penicillin-streptomycin and then preplated for 1.5 h at 37°C to allow fibroblasts to adhere to the plate. Unadhered cells were pelleted again and resuspended in DMEM containing 10% FBS, 1% penicillin-streptomycin, and bromodeoxyuridine (1:100, to inhibit fibroblast growth) and then finally plated at a concentration of ϳ10 6 cells/35-mm plate. Neonatal mouse ventricular myocytes (NMVMs) were isolated from 3-day-old C57BL/6 mice and cultured with the method described above for culturing NRVMs.
Manipulation of KCNE2 expression in cardiac myocytes. Cultured myocytes were infected with recombinant adenovirus vectors carrying human KCNE2 (Ad-KCNE2) and green fluorescent protein (GFP) at a multiplicity of infection (MOI) of 5, with GFP adenovirus (Ad-GFP) applied at the same MOI as the control. Recombinant adenovirus for silencing endogenous KCNE2 expression (KCNE2-shRNA, at a MOI of 10) was prepared with the BLOCK-iT Adenoviral RNAi Expression system (Invitrogen). The sequences of the oligonucleotides for KCNE2 RNA interference were as follows: forward 5=-CACCGGATTGGCAGCAGAAGTATAGCGAACTATACTTC-TGCTGCCAATCC-3= and reverse 5=-AAAAGGATTGGCAGCA-GAAGTATAGTTCGCTATACTTCTGCTGCCAATCC-3=. Adenoviral vectors containing a scrambled short hairpin (sh)RNA sequence (Ctrl-shRNA) at the same MOI served as the control. Experiments were performed 48 h after adenoviral transfection.
Western blot analysis. Protein was extracted 48 h after viral infection. Total cellular extracts were lyzed in Laemmli buffer. The supernatant was ultracentrifuged to pellet membrane fractions, and equal amount of proteins were loaded and separated on 10% SDS-PAGE before being transferred to polyvinylidene difluoride membranes. The membranes were then probed with the following primary antibodies: anti-Kv4.3 (1:200, Alomone, Jerusalem, Israel), anti-K v4.2 (1:200, Alomone), anti-Kv1.4 (1:200, Alomone), anti-KChIP2 (1:1,000, NeuroMab), or anti-KCNE2 (1:200, Alomone) followed by horseradish peroxidase-conjugated secondary antibody (Dako, Ely, UK). Blots were then washed three times in Tris-buffered saline-Tween 20, and the signal was recorded using the Kodak Image Station 2000R System (Kodak). The density of the target protein concentration was determined using NIH ImageJ software and normalized with ␣-actin.
Electrophysiological recording. Ito and IK recordings were performed under the whole cell patch-clamp configuration using a patch amplifier (Axoclamp-200B, Molecular Devices, Sunnyvale, CA) as previously described (32 (24-26°C) . When filled with the pipette solution, pipettes (Garner Glass, Claremont, CA) had resistance ranging from 3 to 5 M⍀. The junctional potential was corrected when the pipette tip entered bath solution. After the cell membrane was broken by the application of additional suction, cell capacitance and series resistance were electrically compensated. The liquid junction potential between the pipette solution and bath solution was estimated to be ϳ10 mV (pipette side negative), which was corrected during data analysis. For the inhibition of Ito or IK, 6 mM or 50 M 4-aminopyridine (4-AP; Sigma, for inhibition of I to in rat cardiomyocytes or I K,slow1 in mouse cardiomyocytes, respectively) or 20 or 25 mM tetraethylammonium [TEA; Sigma, for inhibition of IK in rat cardiomyocytes or IK with slower inactivation kinetics (IK,slow2) in mouse cardiomyocytes, respectively] or 300 nM heteropodatoxin 2 (Abcam, for inhibition of Ito,f in mouse cardiomyocytes) was added, respectively. TEA solution was made by replacing equimolar NaCl with TEA-Cl.
APs were recorded using the current-clamp mode of the whole cell patch-clamp technique as previously described (9) . APs were stimulated with 5-ms square-wave pulses at 1-Hz intervals. The bath solution for AP recording was modified Tyrode solution containing (in mM) 136 NaCl, 5.4 KCl, 0.33 NaH2PO4, 1.0 MgCl2, 10 HEPES, 10 glucose, and 1.8 CaCl 2 (pH 7.4). The pipette solution contained (in mM) 130 KCl, 5.4 NaCl, 1 MgCl 2, 10 HEPES, 5 Mg-ATP, 5 phosphocreatine, and 0.05 cAMP (pH 7.2).
Mathematical model of the AP in ARVMs. A mathematical model of the AP was derived from a previously published left ventricular epicardial cell model (18). All of the current equations and parameters were from the study with minor modification based on the data obtained under our experimental condition. In the original model, the 4-AP-sensitive component (Ito) was not distinguish from the TEA-sensitive component (I K) and the Ca 2ϩ -independent transient outward K ϩ current (It) applied in the model consists of these two components. In the present study, we recorded Ito and IK separately, and It densities applied in the model was the sum of Ito and IK densities.
Statistics. Data are presented as means Ϯ SE. An unpaired two-tailed t-test or one-way ANOVA was used for statistical analysis when appropriate, with P values of Ͻ0.05 being considered significant. . E and F: averages of APD at 20% repolarization (APD20), 50% repolarization (APD50), and 90% repolarization (APD90) in NRVMs (E; Ctrl-shRNA: n ϭ 35 myocytes and 13 rats; KCNE2-shRNA: n ϭ 41 myocytes and 13 rats) and ARVMs (F; Ctrl-shRNA, n ϭ 38 myocytes and 11 rats; KCNE2-shRNA: n ϭ 47 myocytes and 11 rats). G and H: statistics of the resting membrane potential (RMP; G) and amplitude of the AP overshoot (H). *P Ͻ 0.05 and **P Ͻ 0.01 vs. the Ctrl-shRNA group.
RESULTS

Knockdown of KCNE2 prolonged APD in NRVMs and
aging (18 mo old) cardiomyocytes (Fig. 1A ). Considering that KCNE2 may differentially regulate APD and K v channels, we thus did the experiments in both neonatal and adult cardiomyocytes. Knockdown of KCNE2 expression was performed by RNA interference. KCNE2-shRNA infection at a MOI of 10 for 48 h reduced KCNE2 protein levels by 71.3% and 56.6% in neonatal and adult rat cardiomyocytes, respectively, compared with Ctrl-shRNA control cardiomyocytes (Fig. 1, B and C) . In all experiments, APD was measured at 20% repolarization (APD 20 ), 50% repolarization (APD 50 ), and 90% repolarization (APD 90 ). Knockdown of KCNE2 resulted in a prolongation of APD in both neonatal and adult cardiomyocytes (Fig. 1D) . With KCNE2 knockdown, APD 20 , APD 50 , and APD 90 were increased by 17.3% (P Ͻ 0.05), 34.9% (P Ͻ 0.01), and 63.1% (P Ͻ 0.01), respectively, in neonatal cardiomyocytes (Fig. 1E ) and 38.8% (P Ͻ 0.05), 87.7% (P Ͻ 0.01), and 438.1% (P Ͻ 0.01), respectively, in adult cardiomyocytes (Fig. 1F) . The (Fig. 1A) . Second, it has been suggested that "gain of function" mutations of KCNE2 as well as "loss of function" mutations of KCNE2 cause cardiac arrhythmia (12, 28, 31) . Overexpression of KCNE2 may to some extent reflect the effect of gain of function. Finally, it's interesting to know whether there is a redundance in KCNE2 regulation of APD and K v channels. KCNE2 overexpression was performed by adenoviral gene delivery. Ad-KCNE2 infection at a MOI of 5 for 48 h led to ϳ93.1% and 67.0% increases in the KCNE2 protein level, respectively, in neonatal and adult cardiomyocytes compared with Ad-GFP control cardiomyocytes (Fig. 2,  A and B) .
In neonatal cardiomyocytes, KCNE2 overexpression shortened APD. Values of APD 20 , APD 50 , and APD 90 were decreased by 10.8%, 18.0% (P Ͻ 0.05), and 16.9% (P Ͻ 0.05), respectively (Fig.  2, C and D) . In adult cardiomyocytes, however, KCNE2 overexpression had no significant effects on APD (Fig. 2, C  and E) . The resting membrane potential and amplitude of AP overshoot were unaltered by overexpression of KCNE2 in neonatal and adult cardiomyocytes (Fig. 2, F and G) .
KCNE2 regulation of I to densities in rat cardiomyocytes.
To investigate the mechanisms underlying KCNE2 regulations of APD, we studied the effects of bidirectional modulation of KCNE2 on the two major repolarization K ϩ currents, I to and I K . In rat ventricular myocytes, at least two distinct components of Ca 2ϩ -independent, depolarization-activated K ϩ currents have been previously identified (3, 32) . We will use the same terms, "delayed rectifier current" (I K ) denotes the slowly decaying component that is sensitive to TEA and "transient outward current" (I to ) denotes the fast decaying component that is sensitive to 4-AP, as previously used by others (32) . In the measurement of I to , the noninactivating, steady-state outward current (I ss ) recorded at the end of 2-s voltage steps was eliminated.
We first recorded outward current eliminating I K in the presence of 20 mM TEA. The results showed that knockdown of KCNE2 similarly decreased I to in neonatal and adult cardiomyocytes, consistent with the alterations of APD (Fig. 3A) . In neonatal cardiomyocytes, I to densities were significantly decreased at voltages ranging from 10 to 60 mV (P Ͻ 0.05 at 10 mV and P Ͻ 0.01 at 20 -60 mV; Fig. 3D ). In adult cardiomyocytes, I to densities were significantly decreased at voltages ranging from 20 to 60 mV (P Ͻ 0.05 at 20 -40 mV and P Ͻ 0.01 at 50 and 60 mV; Fig. 3G ).
However, KCNE2 overexpression heterologously regulated the magnitude of I to in neonatal and adult cardiomyocytes, where I to densities were significantly increased at voltages ranging from 20 to 60 mV in neonatal cardiomyocytes (P Ͻ 0.05 at 20 -40 mV and P Ͻ 0.01 at 50 and 60 mV; Fig. 4D ) but unaltered at all voltages tested in adult cardiomyocytes (Fig.  4G) . Neither overexpression nor knockdown of KCNE2 had any significant effect on I ss in both types of cardiomyocyte (Figs. 3, C and F, and 4, C and F) .
To explore whether the changes of I to density were related to alterations of protein expression of ␣-and ␤-subunits of I to , we examined membrane protein levels of K v 4.2, K v 4.3, K v 1.4, and KChIP2 and found that neither up-nor downregulation of KCNE2 expression had any significant effect on protein levels of the subunits of I to in neonatal (Fig. 5, A-C ) and adult cardiomyocytes (Fig. 5, D-F) . The results indicate that Ctrl-shRNA KCNE2-shRNA KCNE2 regulation of I to is unrelated to alteration of protein levels of I to subunits. KCNE2 changed I to gating kinetics. Changes in the rates of activation and inactivation of I to were quantified by the time to peak (TTP) and time constant of inactivation () estimated by a monoexponential function of the currents recorded at 0, 20, 40, and 60 mV. We first examined the effects of KCNE2 overexpression on I to gating kinetics in adult cardiomyocytes. The results showed that both TTP and of inactivation were not significantly changed in KCNE2-overexpressing cells (Fig.  6, A and C) . In contrast, knockdown of endogenous KCNE2 resulted in an acceleration of I to activation and inactivation kinetics (Fig. 6C) . The TTP and of inactivation at 60 mV in the KCNE2-shRNA group were 4.1 Ϯ 0.3 and 38.3 Ϯ 2.9 ms, significantly shorter than those in the Ctrl-shRNA group (5.1 Ϯ 0.4 and 49.2 Ϯ 3.9 ms, P Ͻ 0.05; Fig. 6C) .
In neonatal cardiomyocytes, overexpression of KCNE2 slowed the rates of both activation and inactivation of I to , where the TTP and of inactivation at 60 mV in the Ad-KCNE2 group were 14.8 Ϯ 1.2 and 75.3 Ϯ 3.1 ms, much longer than those of 10.1 Ϯ 0.9 and 60.2 Ϯ 3.2 ms in the Ad-GFP group (P Ͻ 0.01; Fig. 6B ). In contrast, knockdown of KCNE2 accelerated the rates of both activation and inactivation of I to , where the TTP and of inactivation in the KCNE2-shRNA group were 9.1 Ϯ 0.7 and 50.4 Ϯ 2.7 ms, significantly shorter than those in the Ctrl-shRNA group (11.3 Ϯ 0.8 and 63.5 Ϯ 2.4 ms, P Ͻ 0.05; Fig. 6B) .
KCNE2 regulated the voltage dependence of I to activation, inactivation, and recovery from inactivation.
The curves of voltage-dependent activation and inactivation were constructed as previously described (13) . In adult cardiomyocytes, upregulation of KCNE2 expression had no significant effect on the voltage-dependent activation and inactivation of I to (Fig. 6, D,  F, G, and I) . The voltages at half-maximum activation (V 0.5,act ) estimated by fitting the activation curve with a Boltzman function were 7.3 Ϯ 0.6 and 8.2 Ϯ 0.7 mV in the Ad-GFP and Ad-KCNE2 groups, respectively (P Ͼ 0.05; Fig. 6, D and F) . The voltages at half-maximum inactivation (V 0.5,inact ) estimated by fitting the inactivation curve with a Boltzman function were Ϫ24.4 Ϯ 1.5 and Ϫ22.9 Ϯ 1.3 mV in the Ad-GFP and Ad-KCNE2 groups, respectively (P Ͼ 0.05; Fig. 6, G and  I) . In contrast, knockdown of KCNE2 caused a mild negative shift of the voltage-dependent activation and inactivation (Fig.  6, E and H) . V 0.5,act was 7.4 Ϯ 0.5 and 4.1 Ϯ 0.3 mV in the Ctrl-shRNA and KCNE2-shRNA groups, respectively (P Ͻ 0.05; Fig. 6, E and F) , and V 0.5,inact was Ϫ24.9 Ϯ 1.4 and Ϫ29.1 Ϯ 1.2 mV in the Ctrl-shRNA and KCNE2-shRNA groups, respectively (P Ͻ 0.01; Fig. 6, H and I) .
Consistent with the alterations in adult myocytes, knockdown of KCNE2 similarly caused a slightly negative shift of voltage-dependent activation and inactivation of I to in neonatal cardiomyocytes. V 0.5,act was 26.8 Ϯ 1.4 and 22.7 Ϯ 1.2 mV in the Ctrl-shRNA and KCNE2-shRNA groups, respectively (P Ͻ 0.05), and V 0.5,inact was Ϫ31.3 Ϯ 1.3 and Ϫ35.6 Ϯ 1.6 mV in the Ctrl-shRNA and KCNE2-shRNA groups, respectively (P Ͻ 0.05). However, in contrast to the results in adult cardiomyocytes, overexpression of KCNE2 positively shifted the voltage-dependent I to activation and inactivation, where V 0.5,act was 27.9 Ϯ 1.1 and 31.8 Ϯ 1.5 mV in the Ad-GFP and Ad-KCNE2 groups, respectively (P Ͻ 0.05), and V 0.5,inact was Ϫ32.8 Ϯ 1.3 and Ϫ29.1 Ϯ 1.7 mV in the Ad-GFP and Ad-KCNE2 groups, respectively (P Ͻ 0.05).
The recovery from inactivation of I to was determined with a double-pulse protocol with recovery intervals from 3 to 1,000 ms at Ϫ80 mV. Since I to densities in neonatal cardiomyocytes were very small, we only analyzed the recovery from inactivation of I to in adults. The result showed that upregulation of KCNE2 expression had no effect on, whereas knockdown of KCNE2 slowed, the I to recovery from inactivation (Fig. 6, J  and K) . The of recovery measured by fitting I to recovery from inactivation with a monoexponential function was 245.7 Ϯ 10.8 and 233.1 Ϯ 8.5 ms in the Ad-GFP and Ad-KCNE2 groups (P Ͼ 0.05) and 240.1 Ϯ 15.4 and 277.7 Ϯ 13.3 ms in the Ctrl-shRNA and KCNE2-shRNA groups (P Ͻ 0.01), respectively (Fig. 6L) .
KCNE2 regulation of I K and I K1 in rat cardiomyocytes. We next explored the effect of bidirectional modulation of KCNE2 expression on I K . Since the amplitudes of I K are too small to be recorded and accurately analyzed, we did the experiments in adult cardiomyocytes. Figure 7A shows that overexpression of KCNE2 reduced I K densities at voltages of 50 and 60 mV (P Ͻ 0.05). The current density at 60 mV was decreased by 10.5%, from 5.3 Ϯ 0.3 pA/pF in the Ad-GFP group to 4.8 Ϯ 0.2 pA/pF in the Ad-KCNE2 group (P Ͻ 0.05; Fig. 7B ). However, knockdown of KCNE2 had no effect on I K densities (Fig. 7C) . Current densities at 60 mV were 5.1 Ϯ 0.3 pA/pF in the KCNE2-shRNA group and 5.2 Ϯ 0.2 pA/pF in the Ctrl-shRNA group (P Ͼ 0.05). Figure 7D shows typical current traces and average current density-voltage relationships of "background" K ϩ current in KCNE2 overexpression and knockdown cells and their respective controls in adult cardiomyocytes. Neither up-nor downregulation of KCNE2 had any significant effect on I K1 in adult cardiomyocytes (Fig. 7, D-F) . These result are consistent with the above data showing that bidirectional modulation of KCNE2 expression did not affect the resting membrane potential of cardiomyocytes.
Effects of bidirectional modulation of KCNE2 expression on APD and I to in NMVMs. Previous work has reported the effects of KCNE2 knockout on APD and K v currents in mouse ventricular myocytes (22) . We also examined the regulation of endogenous KCNE2 on the electrophysiological properties in NMVMs by bidirectional manipulation of KCNE2 expression. Table 1 shows that bidirectional modulation of KCNE2 had similar effects on APD in NMVMs as in NRVMs, where overexpression of KCNE2 shortened and knockdown of KCNE2 prolonged APD.
It has been suggested that murine ventricular myocytes present four kinetically distinct K v currents: I to,f , which is present in myocytes from the apex and some from the septum; slow I to (I to,s ), which is present in septal myocytes, and I K,slow and I ss , which are present in all myocytes (30) . In cultured NMVMs, we cannot distinguish currents from different parts of ventricular myocytes. We thus distinguished I to,f , I K,slow1 , and I K,slow2 with specific inhibitors, as reported in a previous study (22) . The results show that mean peak outward current densities were significantly increased by KCNE2 overexpression but decreased by KCNE2 knockdown (Fig. 8, A and B) . In parallel, heteropodatoxin 2-sensitive I to,f densities were significantly decreased by KCNE2 knockdown but remarkably increased by KCNE2 overexpression (Fig. 8, C and D) . Analyzing the activation and inactivation kinetics revealed representative IK traces in the Ad-GFP, Ad-KCNE2, Ctrl-shRNA, and KCNE2-shRNA groups. B and C: average current density-voltage relationships of IK in the Ad-GFP and Ad-KCNE2 groups (B) or Ctrl-shRNA and KCNE2-shRNA groups (C) (n ϭ 13, 10, 11, and 10 in the Ad-GFP, Ad-KCNE2, Ctrl-shRNA, and KCNE2-shRNA groups, respectively, and 6 rats). D: representative IK1 traces in the Ad-GFP, Ad-KCNE2, Ctrl-shRNA, and KCNE2-shRNA groups. E and F: average current density-voltage relationships of IK1 in the Ad-GFP and Ad-KCNE2 groups (E) or Ctrl-shRNA and KCNE2-shRNA groups (F) (n ϭ 13, 10, 11, and 10 in the Ad-GFP, Ad-KCNE2, Ctrl-shRNA, and KCNE2-shRNA groups, respectively, and 5 rats). *P Ͻ 0.05 vs. the Ad-GFP group. that overexpression of KCNE2 slightly but significantly slowed the kinetics of I to activation and inactivation, whereas knockdown of KCNE2 had the contrary effect. The TTP and of inactivation at 60 mV in the Ad-KCNE2 group were 11.2 Ϯ 0.4 and 100.8 Ϯ 5.7 ms, much longer than those of 9.9 Ϯ 0.5 and 88.2 Ϯ 4.4 ms in the Ad-GFP group (P Ͻ 0.05). In contrast, the TTP and of inactivation in the KCNE2-shRNA group were 7.6 Ϯ 0.3 and 70.1 Ϯ 2.8 ms, significantly shorter than 9.1 Ϯ 0.4 and 81.0 Ϯ 3.2 ms in the Ctrl-shRNA group. Protein levels of K v 4.2 and K v 4.3, which mediate I to,f , remained unaltered (Fig. 8, I and J). The results are in general agreement with KCNE2 regulation of I to in NRVMs.
I K,slow in mouse ventricular myocytes has two pharmacologically distinct components: a 50 M 4-AP-sensitive current mediated by K v 1.5 (I K,slow1 ) and a 25 mM TEA-sensitive current mediated by K v 2.1 (I K,slow2 ). The results show that knockdown of KCNE2 significantly decreased I K,slow1 , whereas overexpression notably increased I K,slow1 (Fig. 8, E  and F) . Neither overexpression nor knockdown of KCNE2 had any effect on I K,slow2 (Fig. 8, G and H) and I ss (data not shown). The results are consistent with a previous study (22) in KCNE2 knockout mice but in contrast with the regulation of I K in rat ventricular myocytes. Given that K v 1.5 is exclusively present in the atria and responsible for ultrarapid activating delayed rectifier K ϩ current (I Kur ), except in mouse ventricles (23) , it is rational that KCNE2 had less effect on I K in rat ventricular myocytes than in mouse cells. Of note, we found that the protein level of K v 1.5 (ϳ80 kDa, the mature form of K v 1.5) was not significantly affected by either KCNE2 overexpression or knockdown (Fig. 8, I and J) . In KCNE2 knockout mice, the mature form of K v 1.5 has been shown to be decreased. The difference might be due to developmental compensation in KCNE2 knockout mice. Nevertheless, the modulation of KCNE2 on I K,slow1 found in our study can be explained by KCNE2 interacting with K v 1.5 and promoting its surface expression, as shown by a previous study (22) .
Mathematical model of the AP in adult rat cardiomyocytes with KCNE2 overexpression or knockdown. To establish a quantitative link between alterations in I to and APD in response to KCNE2 manipulation, we resorted to a mathematical model of AP derived from adult rat left ventricular myocytes (18). Since there is no mathematical model of the AP for neonatal cardiomyocytes available, the AP modeling was done only in adult myocytes. The original model was constructed based on data obtained from freshly isolated myocytes, which are different than the data obtained from cells cultured for 48 h under our experimental conditions; we thus made modifications to the following ionic current properties based on our experimental data: I t density was decreased by 19%, of I t inactivation at voltages positive to 0 mV was changed to 52.0 ms (35.0 ms in the original model), and Ca 2ϩ current density was decreased by 30%. Values of the simulated resting membrane potential, peak overshoot of the AP, APD 50 , and APD 90 are shown in Table 1 . We found that APD 90 in the simulated control group was much shorter than that in the experimental control group, which might be due to alterations in many other factors, such as Na ϩ /Ca 2ϩ exchanger current, Na ϩ -K ϩ pump current, sarcolemmal Ca 2ϩ pump current, etc., under our experimental conditions.
In KCNE2-overexpressing cells, I t density was decreased by 2.1%, whereas the other parameters were unaltered. The simulated AP shape and APD were almost the same as those in the Ad-GFP control group (Fig. 9A and Table 2 ). In KCNE2 knockdown cells, I t density was decreased by 13%, of I t inactivation at voltages positive to 0 mV was changed to 38.2 ms, and V 0.5,inact was negatively shifted by 4 mV. With these alterations, the simulated APD was prolonged, where APD 50 and APD 90 were increased by 53.4% and 44.9%, respectively ( Fig. 9B and Table 2 ). Simulated resting membrane potential and peak overshoot of the AP were unaltered in either KCNE2-overexpressing or KCNE2 knockdown cells, consistent with the results under our experimental conditions (Table 2) .
DISCUSSION
The present study provides the first comprehensive characterization of bidirectional modulations of the protein expression of endogenous KCNE2, the promiscuous auxiliary subunit, in the regulation of APD and repolarization-related K v channels in native NRVMs, ARVMs, and NMVMs. The major findings are threefold. First, knockdown of KCNE2 consis- Values are means Ϯ SE; n ϭ 15-28 in the Ad-GFP, Ad-KCNE2, Ctrl-shRNA, and KCNE2-shRNA groups. APD20, action potential duration at 20% repolarization; APD50, action potential duration at 50% repolarization; APD90, action potential duration at 90% repolarization. *P Ͻ 0.05 vs. the Ad-GFP group; #P Ͻ 0.05 vs. the Ctrl-shRNA group. However, moderate overexpression of KCNE2 shortened APD in neonatal cardiomyocytes but had no effect on APD in adult cardiomyocytes. Second, bidirectional modulations of KCNE2 expression regulated I to densities in parallel to the alterations of APD. Knockdown of KCNE2 decreased I to densities in both neonatal and adult cardiomyocytes, whereas overexpression of KCNE2 increased I to densities in neonatal but not adult cardiomyocytes. Finally, in neonatal cardiomyocytes, knockdown of KCNE2 expression accelerated the gating kinetics and caused a positive shift of both voltage-dependent activation and inactivation of I to , whereas overexpression of KCNE2 had the contrary effects on the gating properties of I to . In adult cardiomyocytes, knockdown of KCNE2 had the same effects on the gating properties of I to as in neonatal cardiomyocytes, but overexpression of KCNE2 again had no effect on them. KCNE2 had little effect on I K in rat ventricular myocytes but significantly upregulated K v 1.5-mediated I K,slow1 density in mouse ventricular myocytes. Since K v 1.5 is exclusively present in the atria and responsible for I Kur , except in mouse ventricles (23) , the role of KCNE2 in the regulation of K v 1.5-mediated current may play an important role in maintaining electrical stability in the atria rather than in the ventricles in the human heart. KCNE2 modulation of I to in cardiomyocytes. A number of studies have shown that KCNE2 modulates I to , but the results are controversial. Zhang et al. (33) reported that KCNE2 dose dependently regulated the current amplitude of K v 4.2 expressed in Xenopus oocytes and slowed the rates of K v 4.2 activation and inactivation, positively shifting voltage -dependent channel gating and accelerating the recovery of the channel from inactivation. KCNE2 regulation of K v 4.3 has also been investigated in mammalian cell lines, where KCNE2 similarly regulated the gating properties of K v 4.3, just like K v 4.2. However, KCNE2 significantly reduced K v 4.3 current densities (11, 28) . Using KCNE2 knockout mice, Roepke et al. (22) demonstrated that deletion of KCNE2 significantly decreased I to densities in cardiomyocytes. In contrast to the findings in the heterologous expression system, deletion of KCNE2 had no effect on I to gating kinetics. The effects of deletion of KCNE2 on voltage-dependent activation and inactivation of I to were not examined.
Resorting to adenoviral gene delivery and RNA interference to either increase or decrease KCNE2 expression in native NRVMs, ARVMs, or NMVMs, we found in this study that bidirectional modulation of KCNE2 protein heterologously regulated I to densities in neonatal and adult cardiomyocytes. Knockdown of KCNE2 decreased I to densities in both neonatal and adult myocytes, which is in agreement with findings in KCNE2 knockout mice (22) . However, overexpression of KCNE2 increased I to densities in neonatal myocytes but not adult myocytes. Two implications can be derived from these findings. First, endogenously expressed KCNE2 plays an essential role in maintaining physiological I to densities in ventricular myocytes. Thus, knockdown of KCNE2 results in a decrease of I to densities in both neonatal and adult myocytes. Second, KCNE2 contributes to the developmental increase of I to densities from neonatal to adult ventricular myocytes. It is known that I to densities increase with the growth of age. This has also been shown in our study, where I to densities in adult cardiomyocytes were much bigger than those in neonatal cardiomyocytes. The bigger I to in adults has been suggested to Overexpression of KCNE2 slowed the rates of activation and inactivation kinetics of I to in neonatal cardiomyocytes but had no effect on the gating properties in adult cardiomyocytes, which might also be due to the saturating effect of KCNE2 in adults. These findings are in general agreement with previous observations of KCNE2 regulation of I to gating kinetics in a heterologous expression system (33) . However, bidirectional manipulation of KCNE2 had only slight regulatory effects on voltage-dependent activation and inactivation as well as recovery from inactivation in cardiomyocytes, which is in contrast to the strong regulatory effects of KCNE2 on these properties in a heterologous expression system (33) . It is well documented that heterologously expressed KChIP2 strongly regulates these channel properties, similar to KCNE2. Our present findings suggest that these I to properties may be dominantly modulated by native KChIP2 and less affected by KCNE2 in the context of cardiomyocytes.
Mechanisms underlying KCNE2 modulation of APD in cardiomyocytes. One of the most important findings in this study is that native cardiac KCNE2 differentially regulates APD in neonatal and adult myocytes. Knockdown of KCNE2 prolonged APD in both neonatal and adult cardiomyocytes. However, overexpression of KCNE2 shortened APD in neonatal cardiomyocytes but had no effect in adult cardiomyocytes. It is well known that I to underlies the initial, rapid repolarization phase of the AP, and I K is responsible for the subsequent, slower phase of AP repolarization back to the resting membrane potential (3). In adult rat ventricular myocytes, I K is relatively small, so the larger I to is responsible for the spike-like morphology of the AP (17, 25) . The quantitative link between I to and APD in response to KCNE2 manipulation was assessed by applying alterations of I to and I K to a mathematical model of the adult rat APD. In KCNE2 knockdown cells, the alterations in I to densities and gating properties resulted in a prolongation of APD as estimated by the mathematical model. The simulated APD 50 and APD 90 were increased by 53.4% and 44.9%, respectively, which were comparable to those (APD 50 and APD 90 were increased by 87.7% and 38.2%) calculated from experimentally recorded APDs. In KCNE2-overexpressing cells, I K densities were slightly decreased and I to remained unaltered, resulting in a 2.1% decrease in I t (the sum of I to and I K ). The simulated APD was less altered, which is also comparable to experimentally recorded APDs. The data collectively indicate that I to is a major contributor to KCNE2 modulation of APD.
Recently, we found that KCNE2 regulated I Ca,L but not Na ϩ current in cardiomyocytes, in which upregulation of KCNE2 by 2.5-fold decreased peak I Ca,L by 18%, whereas downregulation of KCNE2 by 79% increased peak I Ca,L by 29% (12) . The increase in I Ca,L by KCNE2 knockdown may explain the relatively larger experimental APD prolongation compared with simulated APD prolongation. Although a large increase in KCNE2 (by 2.5-fold) decreases I Ca,L amplitude and can shorten APD, this effect may not or only mildly affected APD by KCNE2 overexpression under our experimental conditions because KCNE2 was only moderately increased (by 67%). Previously, it has been reported that KCNE2 expression was decreased in acute myocardial infarction and infarct cardiomyopathy (8, 29) . APD prolongation-related long QT is a prominent manifestation of the diseased heart (10, 26) . That knockdown of KCNE2 prolongs APD suggests that abnormal KCNE2 expression may contribute to the electrical disturbances in the diseased heart.
Limitations. There is a limitation in this study. We only examined the regulatory effect of KCNE2 on AP and K v currents in NRVMs, ARVMs, and NMVMs, where the AP is triangle shaped and I to is the dominant repolarization current in adults. However, the shape of the AP and contribution of I to to the AP in big animal and human cardiomyocytes are quite different from those in rodent cardiomyocytes. In human ventricular myocytes, I to contributes to phase I repolarization and I K (including the fast and slow components of I K ) plays an important role in determining phase II and phase III repolarization. Therefore, caution should be used in translating the present findings to human diseases.
Conclusions. In summary, this study demonstrates, for the first time, that endogenous KCNE2 in cardiomyocytes differentially regulates APD in neonatal and adult cardiomyocytes, which is largely attributed to KCNE2 regulation of I to . These findings highlight the important role of physiological expressed KCNE2 in maintaining cardiac electrophysiological stability by homeostatic regulation of voltage-dependent channels in normal heart and may be a novel view for understanding the pathogenesis of cardiac arrhythmia in diseased hearts.
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